Orion Financial Statements From 2010 to 2025

ORINY Stock  USD 35.28  0.78  2.26%   
Orion Oyj's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Orion Oyj's valuation are provided below:
Orion Oyj ADR does not presently have any trending fundamental ratios for analysis.
Check Orion Oyj financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orion Oyj's main balance sheet or income statement drivers, such as , as well as many indicators such as . Orion financial statements analysis is a perfect complement when working with Orion Oyj Valuation or Volatility modules.
  
This module can also supplement various Orion Oyj Technical models . Check out the analysis of Orion Oyj Correlation against competitors.

Orion Oyj ADR Company Return On Equity Analysis

Orion Oyj's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Orion Oyj Return On Equity

    
  0.41  
Most of Orion Oyj's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orion Oyj ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Orion Oyj ADR has a Return On Equity of 0.4065. This is 101.7% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The return on equity for all United States stocks is notably lower than that of the firm.

Orion Oyj ADR Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Orion Oyj's current stock value. Our valuation model uses many indicators to compare Orion Oyj value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orion Oyj competition to find correlations between indicators driving Orion Oyj's intrinsic value. More Info.
Orion Oyj ADR is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.51  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Orion Oyj ADR is roughly  1.96 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Orion Oyj by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Orion Oyj's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Orion Oyj Financial Statements

Orion Oyj investors use historical fundamental indicators, such as Orion Oyj's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Orion Oyj. Please read more on our technical analysis and fundamental analysis pages.
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients in Finland, Scandinavia, other European countries, North America, and internationally. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland. Orion Oy is traded on OTC Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Orion Pink Sheet Analysis

When running Orion Oyj's price analysis, check to measure Orion Oyj's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orion Oyj is operating at the current time. Most of Orion Oyj's value examination focuses on studying past and present price action to predict the probability of Orion Oyj's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orion Oyj's price. Additionally, you may evaluate how the addition of Orion Oyj to your portfolios can decrease your overall portfolio volatility.